Global Heparin Market Size, Trends, & Growth Opportunity, By Product Type, By Application, By Distribution Channel, By Route of Administration, By Source, By Region and Forecast till 2027.

Global Heparin Market Size, Trends, & Growth Opportunity, By Product Type, By Application, By Distribution Channel, By Route of Administration, By Source, By Region and forecast till 2027.

Global Heparin Market

Global Heparin Market is expected to grow from USD 9.38 billion in 2021 to USD 10.6 billion in 2027 at a CAGR of 3.2% from 2022-2027.

Heparin, also called as unfractionated heparin (UFH), is a glycosaminoglycan which occurs naturally. It is used as an anticoagulant in medicine (blood thinner). It is chiefly used for the treatment of heart attacks and unstable angina. It is injected into the vein or under the skin. Heparin also used to treat various health issues such as acute coronary syndrome, deep vein thrombosis, pulmonary embolism, and atrial fibrillation, as well as cardiopulmonary bypass and hemofiltration during cardiac surgery. Moreover, heparin is administered in major orthopedic surgeries such as hip and knee replacement.

Market Drivers

The Growing incidence of venous thrombosis and cardiovascular diseases is the key component which drives the growth of The Global Heparin Market. Additionally, implementation of heparin in variety of surgeries such as orthopedic and heart surgeries, and increase in number of patients go through such surgeries further boost the growth of heparin market. Also, the availability of synthetic and semi-synthetic heparin derivative which helps to trat cancer, coagulation and inflammatory diseases is anticipated to impart profitable opportunity for heparin usage. Rise in government support for health infrastructure development and comprehensive R&D activities to grow heparin with improved therapeutic potential and less side effects, drive the growth of heparin market.

Market Restraints

Lots of adverse side effect associated with heparin and presence of variety of coagulant in the market may impede the growth of the heparin market. Increasing concern about deficiency of raw material for the manufacturing of porcine based type of heparin are the elements affecting the growth of the heparin market. At the time of lockdown, there was insufficiency of raw material, that was the biggest challenge for the heparin market.

Market Segmentation

The Global Heparin Market is segmented into Product Type, Application, Distribution Channel, Route of Administration, Source. By Product Type such as Unfractionated Heparin (UFH), Low Molecular Weight Heparin (LMWH), Ultra-Molecular Heparin. By Application such as Venous Thromboembolism, Atrial fibrillation, Renal Impairment, Coronary Artery Disease, Others. By Distribution Channel such as Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies. By Route of Administration such as Intravenous Infusion, Subcutaneous Injection. By Source such as Bovine, Porcine.

Regional Analysis

The Global Heparin Market is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, and MEA. North America influences the market and accounted for largest profit share in 2021 owing to increase in cardiovascular disorders and injuries. Also, rising healthcare expenditure level, and increasing patient awareness in this region are the components that can responsible for the region’s high share. In the Asia Pacific, market is expected to witness rapid growth rate during the forecast period. The increasing geriatric population, large population with

chronic disease, and rising economies are some of the primary elements driving the growth of heparin market in this region.

Key Players

Key companies across the Global Heparin Market includes Pfizer Inc., LEO Pharma A/S, Dr. Reddy’s, Laboratories Ltd., GlaxoSmithKline plc, Sanofi, Aspen Holdings, Fresenius SE & Co. KGaA, B. Braun Medical, Inc., Sandoz (Novartis AG)

Market Taxonomy

By Product

• Unfractionated Heparin (UFH)
• Low Molecular Weight Heparin (LMWH)
• Ultra-Molecular Heparin.

• Venous Thromboembolism
• Atrial Fibrillation
• Renal Impairment
• Coronary Artery Disease
• Others.

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

• Intravenous Infusion
• Subcutaneous Injection

• Bovine
• Porcine.

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa